US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Health Innovation Active ETF

32.97

+0.16230.49%

Post-market: 32.96-0.0050-0.02%16:10 EDT

Volume:1K

Turnover:35.22K

Market Cap:13.19M

PE:- -

High:32.98

Open:32.98

Low:32.96

Close:32.80

52wk High:34.86

52wk Low:25.79

Shares:400.00K

Float Shares:400.00K

Volume Ratio:0.45

T/O Rate:0.27%

Dividend:0.08

Dividend Rate:0.25%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

Estee Lauder Cos. Cl a Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains

Edwards Lifesciences to Present at Deutsche Bank Healthcare Summit

Johnson & Johnson to Present at Deutsche Bank 2026 Healthcare Summit

Gilead CEO Daniel O'Day Disposes of USD 2.23 Million in Common Shares

Sector Update: Healthcare

MT Newswires Live

Johnson & Johnson's Drug Pipeline Supports Growth Outlook, UBS Securities Says

MT Newswires Live

LIVE Markets-Wall Street Starts Slow, Dow Leads

Johnson & Johnson Stock (JNJ) Opened Up by 3.15% on Sep 2: Key Drivers Unveiled

Johnson & Johnson, Boeing Share Gains Contribute to Dow's 250-Point Climb

OCUMENSION-B Completes Patient Enrollment in Phase III Trial of Dry Eye Treatment

Novartis Signs Deal Worth up to $3.2 Billion for Alteogen's Drug Delivery Technology

Johnson & Johnson assumed with a Buy at UBS

Is Gilead Sciences (GILD) Fully Valued On Its New HIV And Cancer Drug Approvals?

Simply Wall St.

Johnson & Johnson : UBS Raises Target Price to $320 from $280

THOMSON REUTERS

Merck CFO Litchfield, R&D Chief Li to Speak at Wells Fargo Healthcare Conference

Guangdong Zhongsheng Pharmaceutical (002317.SZ) Secures NMPA Acceptance for Expanded Indication Trial of Onradivir Tablets

CareDx initiated with a Buy at Canaccord

Johnson & Johnson EVP Thomas Cavanaugh Files Initial Beneficial Ownership Statement

Estee Lauder Cos. Cl a Stock Underperforms Tuesday When Compared to Competitors

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/BMED/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BMED","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMED\",,,,,undefined,":{"symbol":"BMED","market":"US","secType":"STK","nameCN":"iShares Health Innovation Active ETF","latestPrice":32.965,"timestamp":1789156800000,"preClose":32.8027,"halted":0,"volume":1067,"hourTrading":{"tag":"盘后","latestPrice":32.96,"preClose":32.965,"latestTime":"16:10 EDT","volume":6,"amount":197.78,"timestamp":1789157404329,"change":-0.005,"changeRate":-0.000152,"amplitude":0},"delay":0,"changeRate":0.004947763446301733,"floatShares":400000,"shares":400000,"eps":0,"marketStatus":"Market Closed","change":0.1623,"latestTime":"09-11 16:00:00 EDT","open":32.98,"high":32.98,"low":32.96,"amount":35217,"amplitude":0.00061,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":32.8027,"sharesOutstanding":360000,"nav":32.792006,"aum":13116802.4,"dividendRate":0.002506,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":32.96,"preClose":32.965,"latestTime":"16:10 EDT","volume":6,"amount":197.78,"timestamp":1789157404329,"change":-0.005,"changeRate":-0.000152,"amplitude":0},"volumeRatio":0.44854549831771684,"impliedVol":0.2836,"impliedVolPercentile":0.761},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMED\",,,,,undefined,":{"symbol":"BMED","floatShares":400000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.44854549831771684,"shares":400000,"dividePrice":0.0826,"high":32.98,"amplitude":0.00061,"preClose":32.8027,"low":32.96,"week52Low":25.794,"pbRate":"--","week52High":34.86,"institutionHeld":0,"latestPrice":32.965,"eps":0,"divideRate":0.002506,"volume":1067,"delay":0,"ttmEps":0,"open":32.98,"prevYearClose":30.32,"prevWeekClose":34.0304,"prevMonthClose":33.8091,"prevQuarterClose":30.62,"fiveDayClose":34.42,"twentyDayClose":32.3479,"sixtyDayClose":28.4912},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BMED\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"BMED","amount":0.08118,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares Health Innovation Active ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2023-12-20","symbol":"BMED","amount":0.007207,"announcedDate":"2023-12-20","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"BlackRock Future Health ETF","recordDate":"2023-12-27","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BMED\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-27","value":0.007207,"currency":"USD"},{"executeDate":"2026-06-15","recordDate":"2026-06-15","paymentDate":"2026-06-18","value":0.08118,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BMED\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BMED\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664841150","title":"Biogen Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2664841150","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664841150?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:56","pubTimestamp":1788382560,"startTime":"0","endTime":"0","summary":"DJ Biogen Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Biogen Inc.  rose 3.07% to $222.67 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.46% to 7,666.60 and the Dow Jones Industrial Average  rising 0.56% to 53,061.95.The stock's rise snapped a three-day losing streak.Biogen Inc. closed 0.08% short of its 52-week high of $222.85, which the company achieved on August 25th.The stock outperformed some of its competitors Wednesday, as Johnson & Johnson  rose 1.48% to $275.21, Pfizer Inc.  rose 1.65% to $29.02, and AbbVie Inc.  rose 0.67% to $261.72.Trading volume  eclipsed its 50-day average volume of 1.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 2, 2026.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z9Z06.USD","BK4588","IE00B894F039.SGD","BMED","BK4585","BIIB","BK4139","LU0109394709.USD","IE00B19Z9P08.USD","LU0320765992.SGD","PBE","BK4532","LU0234570918.USD","LU0889565916.HKD","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664841904","title":"Estee Lauder Cos. Cl a Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2664841904","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664841904?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:54","pubTimestamp":1788382440,"startTime":"0","endTime":"0","summary":"DJ Estee Lauder Cos. Cl A Stock Underperforms Wednesday When Compared To Competitors Despite Daily GainsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Estee Lauder Cos. Cl A  advanced 1.15% to $101.15 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.46% to 7,666.60 and the Dow Jones Industrial Average  rising 0.56% to 53,061.95.The stock's rise snapped a three-day losing streak.Estee Lauder Cos. Cl A closed 16.84% below its 52-week high of $121.64, which the company reached on February 3rd.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Johnson & Johnson  rose 1.48% to $275.21, Procter & Gamble Co.  rose 0.98% to $147.64, and Coty Inc. Cl A  rose 2.11% to $2.90.Trading volume  remained 131,050 below its 50-day average volume of 3.0 M.Data source: Dow Jones Market Data, FactSet. Data compiled September ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0061475181.USD","IE00BLSP4239.USD","LU1145028129.USD","JDOC","VHT","LU0943347566.SGD","LU2471134952.CNY","EL","JNJ","LU0096364046.USD","LU1988902786.USD","MEDX","LU0426412945.USD","PJP","IE00B3PB1722.GBP","LU0912757837.SGD","IE00B19Z3B42.SGD","FSTA","IXJ","LU2404859741.USD","LU0787776722.HKD","GDOC","LU2417539215.USD","IYH","BMED","BK4567","FHLC","UGE","GLAM","PG","IHE","IE0001KFT4U8.USD","LU1868837300.USD","FTXH","COTY","TRUH","LU1914381329.SGD","RXL","XLV","LU1066053197.SGD","LU2129689605.HKD","IE000SO60NU8.SGD","LU0098860793.USD","XLP","LU1674673691.USD","IE0000B7K699.USD","IE00B2B36J28.USD","GB00BDT5M118.USD","LU1064131342.USD","TRUO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664149849","title":"Edwards Lifesciences to Present at Deutsche Bank Healthcare Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2664149849","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664149849?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:17","pubTimestamp":1788380264,"startTime":"0","endTime":"0","summary":"Edwards Lifesciences to present at Deutsche Bank Healthcare SummitEdwards Lifesciences will participate in the Deutsche Bank Healthcare Summit on Sept. 16, 2026.CEO Bernard Zovighian is scheduled to p","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL3Nt2XQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999013999.USD","AGNG","EW","IE00BYQQ9H92.USD","SG9999001176.SGD","IE00BN0W2T93.GBP","IE00BN0W2W23.USD","BMED","LU0058720904.USD","IE00BFXG0V08.USD","LU0289739699.SGD","IE00BN0W2V16.EUR","SG9999001176.USD","SGXZ57979304.SGD","LU0345774391.USD","LU0823416689.USD","BK4567","BK4585","BK4082","BK4588","IHI","LU0345774631.USD","BK4504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664849195","title":"Johnson & Johnson to Present at Deutsche Bank 2026 Healthcare Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2664849195","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664849195?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:15","pubTimestamp":1788380117,"startTime":"0","endTime":"0","summary":"Johnson & Johnson to present at Deutsche Bank 2026 Healthcare SummitJohnson & Johnson will present at the Deutsche Bank 2026 Healthcare Summit on Sept. 17, 2026.Management is scheduled for a fireside chat at 12:00 p.m. ET.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Johnson & Johnson published the original content used to generate this news brief on September 02, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL79CHRX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0001KFT4U8.USD","LU1674673691.USD","LU1066051498.USD","XLV","LU2456880835.USD","JDOC","RXL","IXJ","VHT","BMED","LU1221951129.SGD","LU1066053197.SGD","FHLC","LU0426412945.USD","LU1291159041.SGD","IHE","IE0000B7K699.USD","TRUH","LU1244550577.SGD","LU1914381329.SGD","FTXH","IYH","IE00BDGV0183.EUR","LU1585245621.USD","LU0882574055.USD","LU0943347566.SGD","IE000SO60NU8.SGD","IE00BJJMRZ35.SGD","MEDX","LU1066051811.HKD","LU2471134952.CNY","LU0345770993.USD","LU2417539215.USD","IE00B2B36J28.USD","LU0053666078.USD","IE00B19Z3B42.SGD","GDOC","LU0912757837.SGD","LU1066051225.USD","LU0210536198.USD","LU1074936037.SGD","LU1145028129.USD","PJP","IE000M9KFDE8.USD","LU2129689605.HKD","JNJ","LU0098860793.USD","LU0787776722.HKD","IE00BLSP4239.USD","IE00B3PB1722.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664499688","title":"Gilead CEO Daniel O'Day Disposes of USD 2.23 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2664499688","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664499688?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:13","pubTimestamp":1788380002,"startTime":"0","endTime":"0","summary":"Gilead CEO Daniel O'Day disposes of USD 2.23 million in common sharesGilead Sciences Chairman and CEO Daniel Patrick O’Day sold 14,000 common shares on Sep. 1, 2026.Sales priced at about $147.51 to $1","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL5HTC5L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Gilead CEO Daniel O'Day Disposes of USD 2.23 Million in Common Shares","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDI","IE0002270589.USD","LU0861579265.USD","LU2357627491.SGD","LU2324357040.USD","LU0965509010.AUD","LU1057294990.SGD","LU0109394709.USD","BIB","LU1934455277.USD","LU0058720904.USD","LU1934455194.USD","LU0114720955.EUR","BK4583","LU0965509101.SGD","LU1061106388.HKD","IE00BSNM7G36.USD","LU0320765992.SGD","LU0965508806.USD","LU0859254822.USD","LU1066053197.SGD","IBB","LU0823416689.USD","TMED","SG9999015978.USD","LU2087621335.USD","IE00B19Z3B42.SGD","BK4585","LU1585245621.USD","LU1674673691.USD","LU0889565916.HKD","TBXU","LU1023059063.AUD","SG9999015952.SGD","BK4578","IBBQ","BK4568","BBH","GILD","LU0882574055.USD","IE00B7SZLL34.SGD","LU0122379950.USD","LU1066051498.USD","LU0965509283.SGD","IE00B19Z3581.USD","LU0289739699.SGD","LU1571399168.USD","LU1839511570.USD","BMED","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664117843","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2664117843","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664117843?lang=en_us&edition=fundamental","pubTime":"2026-09-03 01:12","pubTimestamp":1788369173,"startTime":"0","endTime":"0","summary":"Healthcare stocks were higher Wednesday afternoon, with the NYSE Healthcare Index and the State Street Health Care Select Sector SPDR ETF  each adding about 0.8%.The iShares Biotechnology ETF  increased 0.6%.In corporate news, Johnson & Johnson  is positioned for accelerating growth, supported by a strong pharma pipeline, UBS said in a note. UBS assumed coverage of the stock with a buy rating and a $320 price target. Shares rose 1.5%.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4534","LU0122379950.USD","JDOC","FTXH","LU0689472784.USD","LU2133065610.SGD","IXJ","SG9999002224.SGD","IHE","LU0943347566.SGD","MEDX","LU1121112475.USD","SG9999013999.USD","IE00BDGV0183.EUR","LU0029874061.USD","IYH","LU0058720904.USD","HCSG","IE0009355771.USD","LU2487616109.SGD","VHT","LU0234572021.USD","IBB","IE0001KFT4U8.USD","LU1506573853.SGD","LU0795875086.SGD","LU2403377893.USD","FHLC","IE00BFXG1179.USD","BK4532","GDOC","LU2417539215.USD","JNJ","LU1244550577.SGD","LU1629891620.HKD","LABU","XBI","BMED","LU1718418525.SGD","LU1032955483.USD","PJP","RXL","IE00BGHQF631.EUR","SGXZ80539844.SGD","LU1228905037.USD","IE000MB6IJN5.SGD","LU1935042991.SGD","BK4550","XLV","TRUH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664133848","title":"Johnson & Johnson's Drug Pipeline Supports Growth Outlook, UBS Securities Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2664133848","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664133848?lang=en_us&edition=fundamental","pubTime":"2026-09-02 23:48","pubTimestamp":1788364129,"startTime":"0","endTime":"0","summary":"Johnson & Johnson  is positioned for accelerating growth, supported by a strong pharma pipeline, UBS Securities said in a note Wednesday.Analysts said they have identified seven major franchises, each with more than $5 billion in potential revenue, creating a $30 billion to over $40 billion pipeline opportunity across immunology and oncology that could support growth well into the next decade.The company is expected to post revenue and earnings per share above consensus through 2030 to 2032, as growth accelerates from its historical 4% to 6% compound annual growth rate to 8% plus CAGR for the rest of the decade driven by a more diversified portfolio of blockbuster medicines, according to the note.The firm said it views Johnson & Johnson as \"one of the cleanest stories in large-cap pharma,\" with no major loss of exclusivity issues in the near term.UBS Securities assumed coverage of Johnson & Johnson with a buy rating and a $320 price target.Price: 275.12, Change: +3.93, Percent Change: ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["JDOC","LU2468319806.SGD","XLV","PJP","SG9999001176.USD","BK4504","RXL","LU0345770308.USD","IE00B1BXHZ80.USD","GDOC","LU2487616109.SGD","TRUH","IYH","IE000BZT7R73.USD","LU0210528500.USD","LU0234572021.USD","LU1074936037.SGD","LU2023250330.USD","IE00BJT1NW94.SGD","LU0795875086.SGD","FHLC","LU1989771016.USD","MEDX","LU0345769631.USD","LU2236285917.USD","IE00B42XCP33.USD","BMED","LU0792757196.USD","LU2417539215.USD","IE0009355771.USD","LU2403377893.USD","FTXH","LU1221951046.USD","LU2430703095.HKD","VHT","IE00BN8TJ469.HKD","LU1674673691.USD","IE00BJJMRZ35.SGD","LU2471134796.USD","IE0000B7K699.USD","LU1551013342.USD","LU2133065610.SGD","IE00BLSP4452.SGD","IHE","LU2602419157.SGD","JNJ","LU2129689605.HKD","IXJ","LU0345770993.USD","LU2471134879.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664817579","title":"LIVE Markets-Wall Street Starts Slow, Dow Leads","url":"https://stock-news.laohu8.com/highlight/detail?id=2664817579","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664817579?lang=en_us&edition=fundamental","pubTime":"2026-09-02 22:12","pubTimestamp":1788358343,"startTime":"0","endTime":"0","summary":"CLICK HEREWHO WILL POLICE THE BOND VIGILANTES?","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nL6N44U0XT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066053197.SGD","BK4585","LU1983299246.USD","LU0114720955.EUR","LU0466842654.USD","LU1145028129.USD","DGRW","LU2112291526.USD","LU1032955483.USD","IE00B1BXHZ80.USD","LU2750360997.AUD","PJP","LU1244550221.USD","JDOC","LU2896262040.SGD","LU0289739699.SGD","SPHD","IVV","GPIX","IE0000B7K699.USD","IE0034235303.USD","LU1221951129.SGD","TRUH","VTI","LU1674673691.USD","LU1674673428.USD","DVY","BK4568","LU1261432733.SGD","LU1718418525.SGD","SMAX","LU0098860793.USD","LU2089984988.USD","IVE","MEDX","BK4588","SDY","SPYU","LU0689626769.HKD","XYLD","LU1074936037.SGD","IE00BGHQF631.EUR",".SPX","IE00BDGV0183.EUR","VHT","SPXS","IYH","IE000BZT7R73.USD","LU1935042991.SGD","IE00BVYPNV92.GBP","SG9999013999.USD","SPYG","SPYH",".DJI","IE00BJJMRZ35.SGD","MMAX","SCHB","IE0002270589.USD","VEU","LU2471134796.USD","DGRO","IE00B3PB1722.GBP","LU2129689514.USD","DJX","SG9999001176.USD","SG9999002224.SGD","VOOG","LU1228905037.USD","LU0820561909.HKD","LU1430594728.SGD","LU0432979614.USD","LU2471134952.CNY","IE00B42XCP33.USD","BK4504","SG9999001176.SGD","SPLV","IE00B4R5TH58.HKD","LU1585245621.USD","LU2430703251.USD","LU0345769128.USD","ITOT","LU0795875169.SGD","LU0820561818.USD","LU1894683348.USD","LU1057294990.SGD","SPUS","LU0964807845.USD","SPY","SH","FTXH","LU0345770308.USD","LU0122379950.USD","MOAT","ACWI","LU0882574055.USD","LU1496350502.SGD","BK4592","LU1506573853.SGD","LU0345770993.USD","LU2430703178.SGD","SSO","FDN","JNJ","VYMI","LU1196500208.SGD","LU0943347566.SGD","LU0820562030.AUD","LU1059921491.USD","BK4007","IE00B7SZLL34.SGD","LU0640476718.USD","LU0994945656.USD","LU1629891620.HKD","ALLW","LU1989771016.USD","SPGP","LU0985320562.USD","UDOW","IJR","LU1221951046.USD","VOO","LU2417539215.USD","SG9999002232.USD","LU1778281490.HKD","LU2468319806.SGD","BK4559","TSPY","LU2471134879.HKD","SPMO","RSPA","DMAX","BMAY","IVW","LU2487616109.SGD","IE00B19Z3B42.SGD","SFY","IE00BVYPNW00.USD","LU2403377893.USD","IXJ","IJH","DIA","YSPY","LU1244550577.SGD","LU2456880835.USD","GSLC","RXL","SPDN","IE00B19Z3581.USD","TOPT","LU0689472784.USD","LU2756315318.SGD","LU0070217475.USD","IE0001KFT4U8.USD","JEPI","IE00B3T34201.USD","LU0795875086.SGD","SPUU","BK4581","LU1732800096.USD","LU1894683264.USD","IE000MB6IJN5.SGD","LU0912757837.SGD","LU1914381329.SGD","IHE","DXD","SGXZ57979304.SGD","IE00BLSP4239.USD","YMAX","IE00BLSP4452.SGD","VYM","SCHD","IE0002141913.USD","IE0009355771.USD","UPRO","SDOW","LU0203347892.USD","LU1061106388.HKD","LU2430703095.HKD","MGK","SPXU","VV","LU1228905540.USD","LU1929549753.HKD","MYMmain","LU0792757196.USD","BK4534","LU0203345920.USD","BMED","LU1551013425.SGD","BK4533","SDS","LU1280957306.USD","LU2602419157.SGD","IE000SO60NU8.SGD","LU2592432038.USD","LU2213496289.HKD","LU2505996681.GBP","XLG","IE00BZ1G4Q59.USD","LU0787776722.HKD","LU0162691827.USD","RSPN","XLI","LU0889566641.SGD","LU2133065610.SGD","DJIA","LU0545562505.USD","SCHG","SPXL","SPYV","FHLC","XLV","SPYM","DOG","LU1244550494.USD","LU0072461881.USD","LU1551013342.USD","LU0053666078.USD","LU1043141123.HKD","LU0683600562.USD","SPYQ","LU1032466523.USD","HIBS","SG9999001440.SGD","SPYD","SPHQ","LU2347655156.SGD","NOBL","IE00BJT1NW94.SGD","LU1066051811.HKD","LU2236285917.USD","DDM","VBK","IE00BN8TJ469.HKD","BK4550","LU1162221912.USD","GDOC","LU2505996509.AUD","RSP","IE00BSNM7G36.USD","LU0210528500.USD","LU0210536198.USD","LU0234570918.USD","IE000F7OJYX1.SGD","LU2023250330.USD","GRNY","VTV","LU1066051225.USD","RSPU","NQGM","LU0345769631.USD","HIBL","BK4532","IE00BFXG1179.USD","SGXZ80539844.SGD","IE00BFTCPJ56.SGD","LU0058720904.USD","IE000M9KFDE8.USD","LU2129689431.USD","FDVV","LU1291159041.SGD","LU2471134523.USD","ETFT","XDTE","LU0124676726.USD","LU0234572021.USD","LU2750360641.GBP","LU0426417589.USD","LU1023059063.AUD","LU1066051498.USD","LU1121112475.USD","SCHX","IE000WAW04H5.SGD","IE00B2B36J28.USD","DBSC","LU1267930813.SGD","LU1732799900.SGD","LU0320765646.SGD","LU1043141396.HKD","IE00BKVL7J92.USD","LU2129689605.HKD","LU0426412945.USD","LU2756315664.SGD","IE00BBT3K403.USD","VUG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664817097","title":"Johnson & Johnson Stock (JNJ) Opened Up by 3.15% on Sep 2: Key Drivers Unveiled","url":"https://stock-news.laohu8.com/highlight/detail?id=2664817097","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664817097?lang=en_us&edition=fundamental","pubTime":"2026-09-02 21:47","pubTimestamp":1788356841,"startTime":"0","endTime":"0","summary":"• Johnson & Johnson shares rose due to defensive sector rotation into healthcare equities.\n• Progress on talc litigation and FDA clearances bolstered investor confidence and growth strategy.\n• The company posted strong quarterly earnings, raising full-year operational guidance.","market":"fut","thumbnail":"https://resource.tradingkey.com/uploads/20250314/d38d57c8dfb24421a5b88ef27a9554e3shutterstock_2383470839_optimized_150.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20250314/d38d57c8dfb24421a5b88ef27a9554e3shutterstock_2383470839_optimized_150.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262146558-market-movers-jnj-20260902","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1778281490.HKD","IE00BLSP4239.USD","BK4504","JDOC","LU1244550221.USD","VHT","LU2756315318.SGD","LU2471134952.CNY","LU0466842654.USD","BK4550","IE00B7SZLL34.SGD","LU2430703095.HKD","LU1043141123.HKD","BK4585","LU0234570918.USD","LU1732800096.USD","LU0994945656.USD","IE00B19Z3B42.SGD","IXJ","LU2456880835.USD","LU2471134879.HKD","LU2430703178.SGD","LU0787776722.HKD","LU1929549753.HKD","SG9999001176.USD","IE00BGHQF631.EUR","LU1196500208.SGD","LU1267930813.SGD","LU0795875169.SGD","LU1221951046.USD","LU1732799900.SGD","LU2129689514.USD","BK4588","SG9999002232.USD","SG9999001176.SGD","LU0203347892.USD","IE000WAW04H5.SGD","LU1914381329.SGD","LU1023059063.AUD","LU0124676726.USD","LU0795875086.SGD","BK4592","LU2129689605.HKD","RXL","IE00BN8TJ469.HKD","IE0002141913.USD","LU1066051498.USD","LU0070217475.USD","LU0058720904.USD","LU1244550494.USD","LU0345769128.USD","LU0320765646.SGD","LU0820561818.USD","LU2896262040.SGD","LU0072461881.USD","IE00BDGV0183.EUR","LU0792757196.USD","LU2129689431.USD","LU1032955483.USD","MEDX","PJP","LU0889566641.SGD","IE00B3PB1722.GBP","LU2471134523.USD","GDOC","IYH","BMED","IE00BLSP4452.SGD","SG9999013999.USD","LU0210528500.USD","LU0432979614.USD","LU1430594728.SGD","BK4568","LU2089984988.USD","LU1074936037.SGD","LU2471134796.USD","LU0345769631.USD","IE0001KFT4U8.USD","IE00BVYPNW00.USD","IE00BBT3K403.USD","LU1551013342.USD","LU2023250330.USD","IE0009355771.USD","IE00BJT1NW94.SGD","LU0689472784.USD","LU1061106388.HKD","XLV","LU0985320562.USD","IE00BVYPNV92.GBP","LU0964807845.USD","LU0053666078.USD","LU0122379950.USD","LU1496350502.SGD","IE00B19Z3581.USD","LU0162691827.USD","LU1894683264.USD","BK4533","LU1059921491.USD","LU0545562505.USD","LU1221951129.SGD","LU2750360641.GBP","LU0203345920.USD","IE0000B7K699.USD","LU2213496289.HKD","LU2133065610.SGD","SG9999002224.SGD","LU0820562030.AUD","IE00B42XCP33.USD","LU1145028129.USD","SGXZ57979304.SGD","LU1162221912.USD","LU1066051811.HKD","LU0943347566.SGD","JNJ","LU1585245621.USD","LU1935042991.SGD","LU2602419157.SGD","IE00BSNM7G36.USD","LU0426417589.USD","LU2236285917.USD","LU1066051225.USD","LU1244550577.SGD","IE000BZT7R73.USD","LU1894683348.USD","IE00BFXG1179.USD","BK4532","LU0882574055.USD","LU2592432038.USD","LU1261432733.SGD","LU1228905540.USD","LU2403377893.USD","IHE","LU2756315664.SGD","IE00B1BXHZ80.USD","BK4581","LU0345770993.USD","LU1551013425.SGD","TRUH","LU1983299246.USD","LU1506573853.SGD","LU2487616109.SGD","LU1066053197.SGD","LU0210536198.USD","SG9999001440.SGD","LU1291159041.SGD","LU2750360997.AUD","LU2505996509.AUD","IE00B4R5TH58.HKD","LU0820561909.HKD","LU0098860793.USD","LU2112291526.USD","IE0002270589.USD","IE00B2B36J28.USD","LU0234572021.USD","BK4559","LU2468319806.SGD","IE000F7OJYX1.SGD","LU1121112475.USD","LU2505996681.GBP","IE000M9KFDE8.USD","LU2430703251.USD","LU2347655156.SGD","IE00BFTCPJ56.SGD","LU0689626769.HKD","LU0426412945.USD","SGXZ80539844.SGD","LU0912757837.SGD","LU1989771016.USD","LU1629891620.HKD","IE000MB6IJN5.SGD","LU1032466523.USD","IE00BZ1G4Q59.USD","LU2417539215.USD","IE00B3T34201.USD","BK4007","FHLC","LU1280957306.USD","LU0640476718.USD","IE00BJJMRZ35.SGD","LU1057294990.SGD","LU0114720955.EUR","FTXH","LU1674673428.USD","LU1043141396.HKD","BK4534","IE000SO60NU8.SGD","LU1718418525.SGD","LU0683600562.USD","IE0034235303.USD","LU1228905037.USD","LU0345770308.USD","LU1674673691.USD","IE00BKVL7J92.USD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664212812","title":"Johnson & Johnson, Boeing Share Gains Contribute to Dow's 250-Point Climb","url":"https://stock-news.laohu8.com/highlight/detail?id=2664212812","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664212812?lang=en_us&edition=fundamental","pubTime":"2026-09-02 21:45","pubTimestamp":1788356700,"startTime":"0","endTime":"0","summary":"DJ Johnson & Johnson, Boeing Share Gains Contribute To Dow's 250-Point ClimbThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Johnson & Johnson and Boeing are seeing strong returns Wednesday morning, lifting the Dow Jones Industrial Average into positive territory.Shares of Johnson & Johnson  and Boeing  are contributing to the blue-chip gauge's intraday rally, as the Dow  was most recently trading 258 points, or 0.5%, higher.Johnson & Johnson's shares have risen $9.11  while those of Boeing have climbed $3.85, or 1.9%, combining for a roughly 77-point bump for the Dow.Also contributing significantly to the gain are Merck , Walt Disney , and Amgen .A $1 move in any one of the 30 components of the Dow equates to a 5.94-point swing.Data source: Dow Jones Market Data, FactSet. Data compiled September 2, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203347892.USD","BK4187","LU2112291526.USD","SG9999013999.USD","LU1061106388.HKD","SGXZ80539844.SGD","VYMI","SG9999001440.SGD","LU2129689514.USD","BK4534","FDVV","IE000MB6IJN5.SGD","LU2213496289.HKD","LU0889566641.SGD","LU1551013425.SGD","FDN","IE00BFXG1179.USD","IE000M9KFDE8.USD","LU1280957306.USD","LU0820561818.USD","LU0072461881.USD","LU2236285917.USD","LU1043141396.HKD","VUG","SG9999001176.SGD","IE00B42XCP33.USD","PPA","ITA","IE00BZ1G4Q59.USD","LU1162221912.USD","LU1066053197.SGD","LU2129689431.USD","LU2089984988.USD","LU0426417589.USD","LU1435385759.SGD","IE00B7SZLL34.SGD","IE00BDGV0183.EUR","BOED","LU1551013342.USD","LU1894683348.USD","LU2133065610.SGD","LU0466842654.USD","LU1023059063.AUD","IE00B2B36J28.USD","LU0345770993.USD","LU1430594728.SGD","DGRO","LU2756315318.SGD","XLI","IE0002270589.USD","LU1732799900.SGD","SGXZ57979304.SGD","DDM","LU0234570918.USD","LU1732800096.USD","LU1121112475.USD","LU0058720904.USD","LU0640476718.USD","PJP","LU0689626769.HKD","DVY","DOG","LU1043141123.HKD","LU1983299246.USD","LU0203345920.USD","LU0820561909.HKD","IE00B1BXHZ80.USD","YMAX","LU1778281490.HKD","MISL","IE000BZT7R73.USD","LU0053666078.USD","LU0787776722.HKD","LU2750360641.GBP","LU1935042991.SGD","LU0795875086.SGD","BK4568","LU0289739699.SGD","LU0320765646.SGD","LU0994945656.USD","LU1196500208.SGD","FHLC","LU1989771016.USD","IE00BVYPNW00.USD","VYM","LU1066051225.USD","LU0912757837.SGD","LU2417539215.USD","BK4559","BK4533","LU0345769128.USD","LU1267930813.SGD","IE00BJJMRZ35.SGD","LU1629891620.HKD","LU2756315664.SGD","LU2896262040.SGD","LU0882574055.USD","IE000F7OJYX1.SGD","LU0943347566.SGD","SCHG","LU2129689605.HKD","LU0689472784.USD","IDEF","LU1244550494.USD","DJX","LU2505996681.GBP","IE00B4R5TH58.HKD","LU2430703251.USD","UDOW","LU0964807845.USD","LU2468319806.SGD","IE000WAW04H5.SGD","LU1032955483.USD","SG9999002232.USD","XLV","BK4588","LU1057294990.SGD","LU1244550221.USD","LU1261432733.SGD","LU2326559502.SGD","SDY","LU2750360997.AUD","GDOC","IE000SO60NU8.SGD","LU0985320562.USD","TOPT","IE00BBT3K403.USD","LU2471134952.CNY","IYH","LU1674673428.USD","TRUH","LU0210528500.USD","LU1506573853.SGD","LU1894683264.USD","LU2471134523.USD","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","LU0795875169.SGD","IE00BFTCPJ56.SGD","LU0683600562.USD","MEDX","IE00B19Z3581.USD","BK4551","LU0432979614.USD","SDOW","BK4581","DIA","BMED","IE0034235303.USD","LU0122379950.USD","BK4564","LU0792757196.USD","LU1244550577.SGD","LU2456880835.USD","LU1429558221.USD","LU2403377893.USD","LU1221951046.USD","FOWF","LU1059921491.USD","VHT","MGK","LU1674673691.USD","BK4007","LU1929549753.HKD","LU2471134796.USD","SCHD","BK4550","IE0002141913.USD","IE0000B7K699.USD","BK4516","IE00B3T34201.USD","LU1228905037.USD","IE00BLSP4452.SGD","IHE","LU2602419157.SGD",".DJI","LU2471134879.HKD","IXJ","BK4592","LU0820562030.AUD","JDOC","SG9999001176.USD","BK4504","IE0001KFT4U8.USD","RXL","LU0345770308.USD","LU0070217475.USD","IE00BKVL7J92.USD","LU0162691827.USD","LU0545562505.USD","IE00BGHQF631.EUR","LU2487616109.SGD","DXD","LU1914381329.SGD","BA","LU0234572021.USD","LU1718418525.SGD","LU1074936037.SGD","BOEG","DJIA","LU1221951129.SGD","LU0124676726.USD","LU2023250330.USD","IE00BJT1NW94.SGD","LU1032466523.USD","LU0345769631.USD","LU1145028129.USD","LU1228905540.USD","DGRW","IE00BLSP4239.USD","LU2592432038.USD","IE0009355771.USD","MYMmain","IE00B3PB1722.GBP","LU0114720955.EUR","FTXH","LU2347655156.SGD","LU2430703095.HKD","IE00BVYPNV92.GBP","IE00BN8TJ469.HKD","LU0098860793.USD","LU1066051498.USD","LU2505996509.AUD","BK4585","LU1066051811.HKD","NATO","LU2430703178.SGD","LU0210536198.USD","LU1496350502.SGD","BK4532","GRNY","JNJ","LU0426412945.USD","BOEU","LU1585245621.USD","SG9999002224.SGD","LU1291159041.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126045427","title":"OCUMENSION-B Completes Patient Enrollment in Phase III Trial of Dry Eye Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1126045427","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126045427?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:16","pubTimestamp":1788351373,"startTime":"0","endTime":"0","summary":"OCUMENSION-B (01477) has announced the completion of patient enrollment for its Phase III clinical trial of OT-211 (TRYPTYR® acotiamide eye drops) in the People's Republic of China, with a total of...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBJ","BK1574","IBBQ","BMED","BK1191","PSYK","01477","MDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664197068","title":"Novartis Signs Deal Worth up to $3.2 Billion for Alteogen's Drug Delivery Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2664197068","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664197068?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:09","pubTimestamp":1788350999,"startTime":"0","endTime":"0","summary":"Novartis signs deal worth up to $3.2 billion for Alteogen's drug delivery technologySept 2 (Reuters)-South Korea's Alteogen196170.KQsaid on Wednesday ithassigned a deal with NovartisNOVN.Sworth up to ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nL4N44U109:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0098860793.USD","LU2491050154.USD","JDOC","LU0965509010.AUD","LU1066053197.SGD","LU0265550359.USD","LU1699723380.USD","LU1116320901.HKD","HRTS","BK4533","LU2361045086.USD","SG9999001176.SGD","BK4516","SG9999002232.USD","LU1093756325.SGD","IE00BJJMRZ35.SGD","IE00BLSP4452.SGD","IE00BN8TJ469.HKD","LU2360032135.SGD","SG9999014575.USD","LU1066051498.USD","BK4559","LU1585245621.USD","LU1037948541.HKD","LU0868494617.USD","LU2361044865.SGD","LU0859254822.USD","LU2125909247.SGD","LU0965508806.USD","SG9999014542.SGD","LU1037948897.HKD","BK4534","NVSEF","LU0106261372.USD","LU0942090050.USD","LU1923622614.USD","LU1917777945.USD","LU1061106388.HKD","LU0122379950.USD","LU1941712348.USD","IXJ","LU2491050071.SGD","LU1934455277.USD","BMED","SG9999002224.SGD","LU2023250843.SGD","LU0265550946.USD","LU0965509101.SGD","LU1291159041.SGD","LU1035773651.USD","IHE","LU0234572021.USD","LU1989772923.USD","IE00BJT1NW94.SGD","LU1989771016.USD","IE00B2B36J28.USD","LU1941712264.USD","LU0203345920.USD","LU1023059063.AUD","LU0208291251.USD","SG9999001176.USD","LU0289739699.SGD","LU1093756168.USD","BK4007","LU1430594728.SGD","SG9999015341.SGD","LU1989772840.SGD","LU0868494708.USD","IE00B4R5TH58.HKD","GDOC","LU0266013472.USD","LU0985320562.USD","SG9999015358.SGD","FHLC","IE0002141913.USD","LU0477156953.USD","LU2361044949.HKD","FTXH","BK4550","LU0823416689.USD","LU1934455863.HKD","LU0211331839.USD","LU1162221912.USD","LU0320765489.SGD","SG9999001440.SGD","LU0130517989.USD","IE00BBT3K403.USD","XLV","LU1069347547.HKD","LU0130102774.USD","LU2106854487.HKD","IE0009355771.USD","PPH","LU0124676726.USD","BK4585","LU2023250504.SGD","LU2125154935.USD","LU0432979614.USD","LU1929549753.HKD","SG9999014567.USD","LU2461242641.AUD","LU0965509283.SGD","LU2112291526.USD","LU2491049909.HKD","LU0648001328.SGD","LU0070302665.USD","SG9999013999.USD","LU0203347892.USD","LU1066051225.USD","LU0980610538.SGD","VHT","LU1974910355.USD","LU1116320737.USD","LU1571399168.USD","LU0238689110.USD","BK4588","SGXZ57979304.SGD","LU1983299246.USD","LU2433249047.HKD","LU0320765646.SGD","LU1057294990.SGD","LU1934455194.USD","TRUH","IYH","LU0006306889.USD","MRK","LU1032466523.USD","LU2468319806.SGD","RXL","PAWZ","LU0058720904.USD","IE00BFTCPJ56.SGD","IE00B1BXHZ80.USD","LU1201861249.SGD","IE00BSNM7G36.USD","LU2357627491.SGD","LU2324357040.USD","IE000M9KFDE8.USD","LU0861579265.USD","LU2125154778.USD","SG9999014559.SGD","LU2125909593.SGD","LU0689626769.HKD","LU1066051811.HKD","IE00BLSP4239.USD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664816065","title":"Johnson & Johnson assumed with a Buy at UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2664816065","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664816065?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:35","pubTimestamp":1788348952,"startTime":"0","endTime":"0","summary":"UBS assumed coverage of Johnson & Johnson with a Buy rating and a price target of $320, up from $280, based on new, higher above-consensus estimate...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/johnson-johnson-assumed-with-a-buy-at-ubs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/johnson-johnson-assumed-with-a-buy-at-ubs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IXJ","IE000MB6IJN5.SGD","IE00BJJMRZ35.SGD","TRUH","LU1732799900.SGD","IE00BSNM7G36.USD","LU0792757196.USD","PJP","IE00BKVL7J92.USD","MEDX","LU0689626769.HKD","LU1674673428.USD","LU1043141396.HKD","BK4559","LU2417539215.USD","IYH","LU1061106388.HKD","LU1430594728.SGD","LU2112291526.USD","BMED","GDOC","IE00B42XCP33.USD","RXL","LU1043141123.HKD","LU0912757837.SGD","LU2505996509.AUD","BK4532","LU1935042991.SGD","LU0820561818.USD","LU2213496289.HKD","LU1145028129.USD","BK4581","FHLC","JNJ","LU0210528500.USD","BK4588","JDOC","BK4504","IE00BFTCPJ56.SGD","IE00BVYPNV92.GBP","IE00BGHQF631.EUR","IHE","FTXH","IE0002141913.USD","LU1989771016.USD","LU2468319806.SGD","VHT","LU1585245621.USD","XLV","LU0098860793.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664381433","title":"Is Gilead Sciences (GILD) Fully Valued On Its New HIV And Cancer Drug Approvals?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664381433","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664381433?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:23","pubTimestamp":1788348209,"startTime":"0","endTime":"0","summary":"Gilead Sciences (GILD) has drawn fresh investor attention after two recent regulatory decisions. The FDA approved Bixlenvo for virologically suppressed adults with HIV, and the European Commission cleared Trodelvy plus Keytruda for certain metastatic triple-negative breast cancer patients.\nThese approvals arrive after a strong run in Gilead Sciences' stock, with a 30-day share price return of 15.14% and a year-to-date share price return of 23.29%, alongside a 36.48% 1-year total shareholder...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/is-gilead-sciences-gild-fully-valued-on-its-new-hiv-and-canc","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/is-gilead-sciences-gild-fully-valued-on-its-new-hiv-and-canc","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","SG9999015952.SGD","LU1934455863.HKD","LU0823416689.USD","LU0058720904.USD","BK4578","LU0965509283.SGD","LU1778281490.HKD","LU1066053197.SGD","TBXU","MEDI","LU0289739699.SGD","IE00B3T34201.USD","IE00BZ1G4Q59.USD","LU1066051498.USD","BIB","SG9999015986.USD","LU1585245621.USD","LU0122379950.USD","IBBQ","LU0859254822.USD","LU1023059063.AUD","BK4568","BK4532","LU2112291526.USD","TMED","LU0889565916.HKD","LU0965509101.SGD","LU1674673428.USD","BBH","LU1934455194.USD","LU2087621335.USD","LU1037948541.HKD","BMED","BK4566","LU1061106388.HKD","LU0114720955.EUR","LU2324357040.USD","IBB","LU2089984988.USD","BK4585","LU0109394709.USD","IE0002270589.USD","LU0882574055.USD","SG9999015978.USD","IE00B19Z3581.USD","LU1674673691.USD","GILD","BK4588","IE00B7SZLL34.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664815119","title":"Johnson & Johnson : UBS Raises Target Price to $320 from $280","url":"https://stock-news.laohu8.com/highlight/detail?id=2664815119","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664815119?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:02","pubTimestamp":1788346971,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nAZN4THURS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4592","LU1066053197.SGD","LU1929549753.HKD","LU0345770308.USD","JNJ","LU0210528500.USD","LU0795875169.SGD","LU2089984988.USD","IHE","LU0426412945.USD","BMED","LU0345770993.USD","FTXH","IXJ","VHT","LU0098860793.USD","LU2471134523.USD","SG9999001440.SGD","BK4568","LU0210536198.USD","LU0912757837.SGD","PJP","RXL","TRUH","FHLC","LU2430703178.SGD","LU0053666078.USD","SG9999013999.USD","LU1145028129.USD","LU1059921491.USD","LU1983299246.USD","BK4533","LU1244550494.USD","IE00BLSP4239.USD","LU1228905037.USD","LU0985320562.USD","MEDX","LU0072461881.USD","JDOC","XLV","BK4534","LU1066051498.USD","LU1778281490.HKD","GDOC","IE000BZT7R73.USD","LU1914381329.SGD","IYH","LU0289739699.SGD","LU0792757196.USD","IE00B42XCP33.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664813043","title":"Merck CFO Litchfield, R&D Chief Li to Speak at Wells Fargo Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664813043","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664813043?lang=en_us&edition=fundamental","pubTime":"2026-09-02 18:45","pubTimestamp":1788345943,"startTime":"0","endTime":"0","summary":"Merck CFO Litchfield, R&D chief Li to speak at Wells Fargo healthcare conferenceMerck will join a fireside chat at the Wells Fargo 21st Annual Healthcare Conference on Sept. 9, 2026, at 2:15 p.m. ET.Participants include CFO Caroline Litchfield, President of Merck Research Laboratories Dean Y. Li.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Merck & Co. Inc. published the original content used to generate this news brief via Business Wire  on September 02, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDLc3JqK8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0251142724.SGD","LU0029864427.USD","LU0238689110.USD","IE0009355771.USD","SG9999014542.SGD","LU2106854487.HKD","BK4501","LU0128525929.USD","LU1917777945.USD","BK4207","RXL","LU0130517989.USD","SG9999015341.SGD","LU2491049909.HKD","LU1116320901.HKD","LU1066053197.SGD","IE00B2B36J28.USD","LU1571399168.USD","LU0265550359.USD","TFNS","LU0256863811.USD","LU1791807156.HKD","SGXZ57979304.SGD","LU1506573853.SGD","LU1814569148.SGD","LU0971096721.USD","LU0266013472.USD","LU0683600562.USD","PAWZ","BK4588","LU0289739699.SGD","LU1201861249.SGD","LU1929549753.HKD","LU1035773651.USD","LU0861579265.USD","LU2357627491.SGD","SG9999001176.SGD","LU1023059063.AUD","LU2324357040.USD","VHT","LU1983299246.USD","BK4504","LU1267930227.SGD","IE00BJT1NW94.SGD","IYF","LU0124676726.USD","WFC","LU0251131958.USD","LU1668664300.SGD","LU0689626769.HKD","LU1934455194.USD","LU1989772840.SGD","IE00BFTCPJ56.SGD","BK4007","LU0742534661.SGD","LU1057294990.SGD","LU1267930573.SGD","LU0070302665.USD","IE00BJJMRZ35.SGD","LU0208291251.USD","IXJ","LU0162691827.USD","LU0211331839.USD","LU1093756168.USD","LU0432979614.USD","LU1267930490.SGD","LU2468319806.SGD","SG9999014559.SGD","XLV","BK4550","LU0072461881.USD","LU1923622614.USD","LU0106261372.USD","LU0267386448.USD","LU0310800965.SGD","LU1032466523.USD","LU2491050154.USD","SG9999014567.USD","LU2361045086.USD","IE000M9KFDE8.USD","JDOC","LU0868494617.USD","IE00BBT3K403.USD","LU2433249047.HKD","LU2491050071.SGD","IE00B1BXHZ80.USD","LU2461242641.AUD","IE0002270589.USD","LU1934455863.HKD","LU2361044949.HKD","LU0128525689.USD","SG9999001176.USD","LU0640476718.USD","LU0859254822.USD","BK4533","LU2023250504.SGD","SG9999014575.USD","LU0310800379.SGD","LU1066051498.USD","IE00B7SZLL34.SGD","LU0234572021.USD","LU1066051811.HKD","LU0965509101.SGD","LU1074936037.SGD","LU2089984988.USD","LU1061106388.HKD","LU2236285917.USD","LU0320765646.SGD","LU1430594728.SGD","LU0965509283.SGD","BMED","TRUH","LU1116320737.USD","LU1069347547.HKD","LU2361044865.SGD","HRTS","LU0823416689.USD","BK4585","LU1941712264.USD","LU0122379950.USD","LU0149725797.USD","LU0265550946.USD","IE00B4R5TH58.HKD","SG9999015358.SGD","LU2125909247.SGD","LU1066051225.USD","LU2125154935.USD","IE00BLSP4239.USD","GDOC","LU0965509010.AUD","LU1699723380.USD","IE00BLSP4452.SGD","LU2023250843.SGD","LU1162221912.USD","MRK","LU1989772923.USD","IE00B19Z3581.USD","SG9999002224.SGD","LU0708994859.HKD","LU0980610538.SGD","LU0211327993.USD","LU1585245621.USD","LU0211328371.USD","BK4534","LU0052756011.USD","IE0002141913.USD","LU0106831901.USD","LU1894683264.USD","BK4559","LU0058720904.USD","LU0154236417.USD","LU1934455277.USD","BK4516","IHE","SG9999001440.SGD","IE00BN8TJ469.HKD","LU1989771016.USD","IE00B19Z3B42.SGD","LU0289960550.SGD","LU0868494708.USD","KBWB","SG9999002232.USD","IE00BSNM7G36.USD","LU2360032135.SGD","LU0203345920.USD","LU2112291526.USD","LU0320765489.SGD","LU1280957306.USD","LU0787776722.HKD","LU1363072403.SGD","LU0203347892.USD","IYH","LU0175139822.USD","LU1037948541.HKD","LU2125154778.USD","LU0648001328.SGD","LU1037948897.HKD","LU0098860793.USD","LU1974910355.USD","LU0006306889.USD","FTXH","LU2125909593.SGD","SG9999013999.USD","LU0130102774.USD","LU0477156953.USD","LU1894683348.USD","LU1941712348.USD","FHLC","LU0942090050.USD","LU0314106906.USD","LU0048573561.USD","LU0985320562.USD","FTXO","LU1291159041.SGD","PPH","LU0417517546.SGD","LU0965508806.USD","LU0310799852.SGD","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179166528","title":"Guangdong Zhongsheng Pharmaceutical (002317.SZ) Secures NMPA Acceptance for Expanded Indication Trial of Onradivir Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=1179166528","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179166528?lang=en_us&edition=fundamental","pubTime":"2026-09-02 18:05","pubTimestamp":1788343503,"startTime":"0","endTime":"0","summary":"Guangdong Zhongsheng Pharmaceutical Co.,Ltd. (002317.SZ) has announced that its controlling subsidiary, Guangdong Zhongsheng Ruichuang Biotech Co., Ltd., recently received formal acceptance from...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBJ","IBBQ","MDTX","BK0188","BK0239","BK0077","BMED","002317","PSYK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664181248","title":"CareDx initiated with a Buy at Canaccord","url":"https://stock-news.laohu8.com/highlight/detail?id=2664181248","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664181248?lang=en_us&edition=fundamental","pubTime":"2026-09-02 17:55","pubTimestamp":1788342924,"startTime":"0","endTime":"0","summary":"Canaccord initiated coverage of CareDx (CDNA) with a Buy rating and $65 price target The company’s leadership position in transplant diagnostics “p...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/caredx-initiated-with-a-buy-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/caredx-initiated-with-a-buy-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMED","BK4139","CDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664386900","title":"Johnson & Johnson EVP Thomas Cavanaugh Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2664386900","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664386900?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:53","pubTimestamp":1788295990,"startTime":"0","endTime":"0","summary":"Johnson & Johnson EVP Thomas Cavanaugh files initial beneficial ownership statementJohnson & Johnson EVP WW Chair, Innovative Med. Thomas Cavanaugh filed a Form 3 disclosing 499 common shares, includi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL58rn8Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","FHLC","LU0994945656.USD","LU2750360997.AUD","LU2430703251.USD","BK4504","LU1732800096.USD","IHE","IE00B19Z3581.USD","LU0964807845.USD","LU1228905540.USD","LU1929549753.HKD","PJP","IE00BVYPNV92.GBP","BMED","GDOC","IXJ","IE00BVYPNW00.USD","LU2112291526.USD","LU2133065610.SGD","IYH","LU0234572021.USD","SG9999013999.USD","LU0689472784.USD","IE00BLSP4452.SGD","VHT","IE000WAW04H5.SGD","TRUH","IE00BKVL7J92.USD","LU1032466523.USD","XLV","LU2213496289.HKD","JDOC","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","JNJ","LU2487616109.SGD","LU1430594728.SGD","MEDX","IE00BSNM7G36.USD","RXL","IE000F7OJYX1.SGD","FTXH","LU2602419157.SGD","LU0943347566.SGD","BK4568","LU0203347892.USD","LU0545562505.USD","LU1496350502.SGD","LU1221951046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664869005","title":"Estee Lauder Cos. Cl a Stock Underperforms Tuesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2664869005","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664869005?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:53","pubTimestamp":1788295980,"startTime":"0","endTime":"0","summary":"DJ Estee Lauder Cos. Cl A Stock Underperforms Tuesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Estee Lauder Cos. Cl A  shed 2.25% to $100.00 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.71% to 7,631.47 and Dow Jones Industrial Average  falling 0.79% to 52,766.88.This was the stock's third consecutive day of losses.Estee Lauder Cos. Cl A closed 17.79% short of its 52-week high of $121.64, which the company reached on February 3rd.The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson  rose 2.01% to $271.19, Procter & Gamble Co.  rose 0.75% to $146.21, and Coty Inc. Cl A  fell 0.35% to $2.84.Trading volume  remained 177,738 below its 50-day average volume of 3.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 1, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLAM","LU2404859667.USD","VHT","IXJ","IE00BDGV0183.EUR","LU0072461881.USD","LU1267930813.SGD","LU0795875169.SGD","MEDX","BK4568","SG9999014559.SGD","TRUH","GDOC","FHLC","LU0210536198.USD","IE000F7OJYX1.SGD","LU0098860793.USD","IE00BVYPNV92.GBP","LU0882574055.USD","PJP","RXL","IE00BJJMRZ35.SGD","LU0432979614.USD","LU1894683348.USD","FTXH","IYH","IE00B2B36J28.USD","EL","IHE","LU0289739699.SGD","TRUO","FSTA","LU1551013342.USD","LU0122379950.USD","LU1059921491.USD","LU1057294990.SGD","JNJ","IE00BZ1G4Q59.USD","JDOC","PG","UGE","SG9999014542.SGD","LU2471134879.HKD","COTY","XLV","XLP","BMED","LU0234572021.USD","IE00B19Z3B42.SGD","LU0237698245.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}